Minerva Neurosciences reported $-0.22 in EPS Earnings Per Share for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US $ 0K 0K
Adma Biologics ADMA:US -0.13 0.01
ALKERMES ALKS:US $ 0.14 0.16
Arena Pharmaceuticals ARNA:US -2.07 0.33
AstraZeneca AZN:LN 1.08 0.18
Biocryst Pharmaceuticals BCRX:US -0.33 0.09
Bristol Myers Squibb BMY:US $ 2 0.07
Dynavax Technologies DVAX:US -0.24 0.26
Eli Lilly And LLY:US $ 1.94 0.07
Esperion Therapeutics ESPR:US -2.62 0.95
GlaxoSmithKline GSK:LN 0.37 0.08
Halozyme Therapeutics HALO:US $ 0.51 0.11
IONIS PHARMACEUT IONS:US $ -0.58 0.01
Johnson & Johnson JNJ:US 2.6 0.12
Kindred Biosciences KIN:US -0.2 0.04
Marinus Pharmaceuticals MRNS:US $ -0.53 0.12
Merk MRK:US $ 1.75 0.44
Minerva Neurosciences NERV:US $ -0.22 0.03
Neurocrine Biosciences NBIX:US $ 0.64 0.21
Novartis NOVN:VX SF 1.71 0.05
Novavax NVAX:US $ -4.31 0.44
Pfizer PFE:US $ 1.34 0.27
Sanofi SAN:FP € 2.18 0.8
Takeda 4502:JP Y 29.24 98.77
Vanda Pharmaceuticals VNDA:US $ 0.14 0.03